'MS Center' Swedish Multiple Sclerosis Blog posts
In response, a number of MS organizations and experts have voiced their concerns that with this step, MS patients are left without a potential choice in therapy. This decision is particularly difficult for ...
The FDA approval is based on data from ...
A recent article has been published suggesting that MS may be caused by a bacterial toxin. The bacteria is Clostridium Perfringens, a common bacteria found in soil and a cause of food poisoning. This bacteria can produce a number of toxins, one of which is the epsilon toxin.
This study found that about 10% of people with multiple sclerosis (MS) had antibodies to the epsilon toxin, compared to 1% of people without MS. In pathology specimens from mice, the epsilon toxin was found to bind to blood vessels in the retina of the eye, and to myelin in the brain. The authors also reported a single case of a woman with MS who was infected with Clostridium Perfringens and that was producing the epsilon toxin.
Though this study has been widely discussed online, I think that it is unlikely that this will be the answer to the MS problem. This study was primarily in pathology tissue, which found that the toxin was able to bind to myelin. Many more studies will be needed to determine whether this toxin is capable of causing damage to myelin of the type that is seen in MS. There are many other known toxins to myelin, but so far none seem to be the cause of MS.
They tried to show that ..
Less than two years old, the Swedish Multiple Sclerosis Center has already received an overwhelming amount of praise from patients and physicians alike for its holistic approach to world class care.
Now we can add one more accolade to the list.
Healthcare Design magazine recently recognized the MS Center’s patient and family waiting area as a finalist in the Family Spaces category of its Healthcare Design Remodel Renovation Competition.The entire piece beautifully encapsulates the approach, design and ultimately the quality of care that the MS Center strives to deliver. Here is an excerpt of one of the judge’s comments:
“The entire design is a phenomenal reflection of a deep understanding of the unique needs of patients with multiple sclerosis. It is apparent the design team did their research, listened to the voice of the patient and caregivers, and integrated evidence-based design principles….”
That’s high praise, and it is rewarding to know that the attention we paid to every detail — from furniture and flooring to treatment and waiting areas — was noticed. But it is even more rewarding to know that the center has become an incredible resource in treating those diagnosed with MS, a degenerative disease that strikes the central nervous system.
Another important question is the role of vaccination in MS. In general, vaccinations do not seem to cause MS attacks. Because the vaccinations do not usually cause MS attacks, but the flu can cause an MS attack about 1 in 10 times, most neurologists recommend that MS patients receive the influenza vaccine. It is ...
The 2013 World Atlas of MS has been published by MS International Foundation and is available here. The key findings are:
- The estimated number of people with MS has increased from 2.1 million in 2008 to 2.3 million in 2013
- The 2:1 ratio of women to men with MS has not changed significantly since 2008
- Substantial global inequalities remain in terms of access to treatment and medical care
I am delighted to write the blog over the Progressive MS session that was given at ECTRIMS 2013. Much emphasis has been given to the need for more research in the fields of progressive MS. The majority of MS patients fit into this broad category: primary progressive MS, secondary progressive MS, and progressive relapsing forms of the disease. During a session devoted to progressive MS, leaders in the field discussed several initiatives underway to address the challenges presented by these forms of the disease.
Rehabilitation is a mainstay and key to improving the lives of patients with progressive MS. Many patients describe their progression in terms of mobility decline, which is a major target of improvement in rehabilitation programs.
The first session was devoted to confusion surrounding the definition of “progression in MS.” We use ...